We keep hearing that vaccines are in short supply and that the manufacturing process in slow with problems meeting all the demands. Today, Health Canada approved the Astrazenca vaccine to be used in Canada and Justin Trudeau approved the purchase of over 2 million doses. Astrazenca is already in demand in many other countries around the world the same Pfizer and Moderna. Diversity is always a good idea but what about the manufacturing issues and is this vaccine going to be effective on all the variants.
This new vaccine will be added to the line to help make sure every Canadian is vaccinated by September
The Government of Canada is taking steps to ensure more people in Canada are vaccinated more quickly, and continues to work to give Canadians access to safe and effective COVID-19 vaccines as soon as possible.
Following Health Canada’s authorization of the AstraZeneca ChAdOx1 COVID-19 vaccine, the Honourable Anita Anand, Minister of Public Services and Procurement, announced today that Canada has secured 2 million doses of the AstraZeneca COVID-19 vaccine through an agreement with Verity Pharmaceuticals Canada Inc./Serum Institute of India.
AstraZeneca has licensed the manufacture of its ChAdOx1 vaccine to the Serum Institute. The first 500,000 doses will be delivered to Canada in the coming weeks and will quickly be ready for distribution to the provinces and territories. The remaining 1.5 million doses will arrive by mid-May.
The 2 million doses secured through this agreement are in addition to the 20 million doses already secured through an earlier agreement with AstraZeneca. Health Canada’s authorization of the AstraZeneca vaccine allows the Government of Canada to advance its work with AstraZeneca to finalize delivery schedules for the 20 million doses.
This announcement further solidifies Canada’s plan to be able to provide a vaccine to everyone in Canada for whom these COVID-19 vaccines are recommended, by the end of September.
Anita Anand, “The Government of Canada continues to do everything possible to protect Canadians from COVID-19. This includes securing a highly diverse and extensive portfolio of vaccines and taking all necessary measures to ready the country to receive them. We remain fully on track to ensure that there will be a sufficient supply so that every eligible Canadian who wants a vaccine will have access to one by the end of September. I am grateful for the collaboration of our partners in India to finalize this agreement, and I look forward to continuing to work closely together in the weeks ahead.”